These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2197952)

  • 1. Epidemiologic aspects of early menopause and ovarian cancer.
    Cramer DW
    Ann N Y Acad Sci; 1990; 592():363-75; discussion 390-4. PubMed ID: 2197952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lactose and galactose intake and metabolism in relation to the risk of epithelial ovarian cancer.
    Herrinton LJ; Weiss NS; Beresford SA; Stanford JL; Wolfla DM; Feng Z; Scott CR
    Am J Epidemiol; 1995 Mar; 141(5):407-16. PubMed ID: 7879785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of women with a family history of ovarian cancer. I. Galactose consumption and metabolism.
    Cramer DW; Muto MG; Reichardt JK; Xu H; Welch WR; Valles B; Ng WG
    Cancer; 1994 Aug; 74(4):1309-17. PubMed ID: 8055453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galactose consumption and metabolism in relation to the risk of ovarian cancer.
    Cramer DW; Harlow BL; Willett WC; Welch WR; Bell DA; Scully RE; Ng WG; Knapp RC
    Lancet; 1989 Jul; 2(8654):66-71. PubMed ID: 2567871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case-control study of galactose consumption and metabolism in relation to ovarian cancer.
    Cramer DW; Greenberg ER; Titus-Ernstoff L; Liberman RF; Welch WR; Li E; Ng WG
    Cancer Epidemiol Biomarkers Prev; 2000 Jan; 9(1):95-101. PubMed ID: 10667469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Milk/dairy products consumption, galactose metabolism and ovarian cancer: meta-analysis of epidemiological studies.
    Qin LQ; Xu JY; Wang PY; Hashi A; Hoshi K; Sato A
    Eur J Cancer Prev; 2005 Feb; 14(1):13-9. PubMed ID: 15677891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galactose-1-phosphate uridyl transferase (GALT) genotype and phenotype, galactose consumption, and the risk of borderline and invasive ovarian cancer (United States).
    Cozen W; Peters R; Reichardt JK; Ng W; Felix JC; Wan P; Pike MC
    Cancer Causes Control; 2002 Mar; 13(2):113-20. PubMed ID: 11936817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Milk consumption, galactose metabolism and ovarian cancer (Australia).
    Webb PM; Bain CJ; Purdie DM; Harvey PW; Green A
    Cancer Causes Control; 1998 Dec; 9(6):637-44. PubMed ID: 10189050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian effects of a high lactose diet in the female rat.
    Liu G; Shi F; Blas-Machado U; Duong Q; Davis VL; Foster WG; Hughes CL
    Reprod Nutr Dev; 2005; 45(2):185-92. PubMed ID: 15954229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The N314D polymorphism of galactose-1-phosphate uridyl transferase does not modify the risk of ovarian cancer.
    Fung WL; Risch H; McLaughlin J; Rosen B; Cole D; Vesprini D; Narod SA
    Cancer Epidemiol Biomarkers Prev; 2003 Jul; 12(7):678-80. PubMed ID: 12869412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary lactose intake, lactose intolerance, and the risk of epithelial ovarian cancer in southern Ontario (Canada).
    Risch HA; Jain M; Marrett LD; Howe GR
    Cancer Causes Control; 1994 Nov; 5(6):540-8. PubMed ID: 7827241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of galactose-1-phosphate uridyltransferase activity and N314D genotype with the risk of ovarian cancer.
    Goodman MT; Wu AH; Tung KH; McDuffie K; Cramer DW; Wilkens LR; Terada K; Reichardt JK; Ng WG
    Am J Epidemiol; 2002 Oct; 156(8):693-701. PubMed ID: 12370157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between calcium, lactose, vitamin D, and dairy products and ovarian cancer.
    Koralek DO; Bertone-Johnson ER; Leitzmann MF; Sturgeon SR; Lacey JV; Schairer C; Schatzkin A
    Nutr Cancer; 2006; 56(1):22-30. PubMed ID: 17176214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galactose consumption, metabolism, and follicle-stimulating hormone concentrations in women of late reproductive age.
    Cooper GS; Hulka BS; Baird DD; Savitz DA; Hughes CL; Weinberg CR; Coleman RA; Shields JM
    Fertil Steril; 1994 Dec; 62(6):1168-75. PubMed ID: 7957979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Habitual dietary lactose and galactose intakes in association with age at menopause in non-galactosemic women.
    Rostami Dovom M; Moslehi N; Mirmiran P; Azizi F; Ramezani Tehrani F
    PLoS One; 2019; 14(3):e0214067. PubMed ID: 30889195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lactase persistence and milk consumption as determinants of ovarian cancer risk.
    Cramer DW
    Am J Epidemiol; 1989 Nov; 130(5):904-10. PubMed ID: 2510499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lactose absorption in patients with ovarian cancer.
    Meloni GF; Colombo C; La Vecchia C; Ruggiu G; Mannazzu MC; Ambrosini G; Cherchi PL
    Am J Epidemiol; 1999 Jul; 150(2):183-6. PubMed ID: 10412963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Müllerian aplasia associated with maternal deficiency of galactose-1-phosphate uridyl transferase.
    Cramer DW; Ravnikar VA; Craighill M; Ng WG; Goldstein DP; Reilly R
    Fertil Steril; 1987 Jun; 47(6):930-4. PubMed ID: 3036608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galactose metabolism and reproductive history in women with type 1 neurofibromatosis.
    Cramer DW; Korf BR; Fortier LJ
    Am J Med Genet; 1991 Jun; 39(4):502-8. PubMed ID: 1908637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian cancer: epidemiology and risk factors.
    La Vecchia C
    Eur J Cancer Prev; 2017 Jan; 26(1):55-62. PubMed ID: 26731563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.